作者:
Lissete,Sánchez-Magraner [1]
;
Juan,Gumuzio [1]
;
James,Miles [1]
;
Nicole,Quimi [1]
;
Purificación,Martínez Del Prado [2]
;
María Teresa,Abad-Villar [2]
;
Fernando,Pikabea [2]
;
Laura,Ortega [2]
;
Carmen,Etxezarraga [2]
;
Salvador,Martín-Algarra [3]
;
María D,Lozano [3]
;
Mónica,Saiz-Camin [4]
;
Mikel,Egurrola-Izquierdo [5]
;
Inmaculada,Barredo-Santamaría [5]
;
Alberto,Saiz-López [5]
;
Jenifer,Gomez-Mediavilla [6]
;
Nerea,Segues-Merino [6]
;
María Aranzazu,Juaristi-Abaunz [6]
;
Ander,Urruticoechea [6]
;
Erica J,Geraedts [7]
;
Kim,van Elst [7]
;
Niels J M,Claessens [8]
;
Antoine,Italiano [9]
;
Christopher J,Applebee [1]
;
Sandra,Del Castillo [1]
;
Charles,Evans [10]
;
Fernando,Aguirre [1]
;
Peter J,Parker [1]
;
Véronique,Calleja [1]
作者单位:
HAWK Biosystems (formerly known as FASTBASE Solutions S.L.), Derio, Bizkaia, Spain.
[1]
Basurto University Hospital, Bizkaia, Spain.
[2]
Clinica Universidad de Navarra, Idisna, Pamplona, Spain.
[3]
Cruces University Hospital, Bizkaia, Spain.
[4]
Galdakao University Hospital, Bizkaia, Spain.
[5]
Gipuzkoa Cancer Unit, OSID-Onkologikoa, Biodonostia, San Sebastián Spain.
[6]
Department of pulmonology, Groene Hart Ziekenhuis, Gouda, the Netherlands.
[7]
Rijnstate Hospital, Arnhem, the Netherlands.
[8]
Early Phase Trials and Sarcoma, Institut Bergonié, Cours de l'Argonne, Bordeaux, France.
[9]
University of the Basque Country (UPV/EHU), Leioa, Spain.
[10]
School of Cancer and Pharmaceutical Sciencess, King's College London, London, United Kingdom.
[11]
Francis Crick Institute, London, United Kingdom.
[12]
DOI
10.1200/JCO.22.01748
PMID
36821809
发布时间
2023-08-12